HIV-1 Vif promotes the G₁- to S-phase cell-cycle transition

Blood. 2011 Jan 27;117(4):1260-9. doi: 10.1182/blood-2010-06-289215. Epub 2010 Dec 13.

Abstract

HIV-1 depends on host-cell resources for replication, access to which may be limited to a particular phase of the cell cycle. The HIV-encoded proteins Vpr (viral protein R) and Vif (viral infectivity factor) arrest cells in the G₂ phase; however, alteration of other cell-cycle phases has not been reported. We show that Vif drives cells out of G₁ and into the S phase. The effect of Vif on the G₁- to-S transition is distinct from its effect on G₂, because G₂ arrest is Cullin5-dependent, whereas the G₁- to-S progression is Cullin5-independent. Using mass spectrometry, we identified 2 novel cellular partners of Vif, Brd4 and Cdk9, both of which are known to regulate cell-cycle progression. We confirmed the interaction of Vif and Cdk9 by immunoprecipitation and Western blot, and showed that small interfering RNAs (siRNAs) specific for Cdk9 inhibit the Vif-mediated G₁- to-S transition. These data suggest that Vif regulates early cell-cycle progression, with implications for infection and latency.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Cycle / drug effects
  • Cell Cycle / genetics*
  • Cell Cycle / physiology
  • Cell Proliferation* / drug effects
  • Cullin Proteins / genetics
  • Cullin Proteins / metabolism
  • Cullin Proteins / physiology
  • Cyclin-Dependent Kinase 9 / antagonists & inhibitors
  • Cyclin-Dependent Kinase 9 / genetics
  • Cyclin-Dependent Kinase 9 / metabolism
  • G1 Phase / drug effects
  • G1 Phase / genetics
  • G1 Phase / physiology
  • Gene Expression Regulation / drug effects
  • HIV Infections / genetics
  • HIV Infections / metabolism
  • HIV Infections / pathology
  • HIV-1 / genetics
  • HIV-1 / physiology
  • HeLa Cells
  • Humans
  • Models, Biological
  • Mutant Proteins / genetics
  • Mutant Proteins / metabolism
  • Protein Binding / drug effects
  • Protein Binding / physiology
  • RNA, Small Interfering / pharmacology
  • S Phase / drug effects
  • S Phase / genetics
  • S Phase / physiology
  • Transfection
  • Virus Latency / drug effects
  • Virus Latency / genetics
  • vif Gene Products, Human Immunodeficiency Virus / genetics
  • vif Gene Products, Human Immunodeficiency Virus / metabolism
  • vif Gene Products, Human Immunodeficiency Virus / physiology*

Substances

  • CUL5 protein, human
  • Cullin Proteins
  • Mutant Proteins
  • RNA, Small Interfering
  • vif Gene Products, Human Immunodeficiency Virus
  • CDK9 protein, human
  • Cyclin-Dependent Kinase 9